在涉及消化系统的腹部手术中,蜂蜜作为碳水化合物负荷的替代来源:一项随机盲法比较研究。

IF 1.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
Malaysian Journal of Medical Sciences Pub Date : 2025-04-01 Epub Date: 2025-04-30 DOI:10.21315/mjms-06-2024-419
Karthik Krishnan, Siti Khatijah Abdul Razak, Mohd Zulkifli Mustafa, Najib Majdi Yaacob, Zalina Zahari, Mohd Shahrulsalam Mohd Shah, Andee Dzulkarnaen Zakaria
{"title":"在涉及消化系统的腹部手术中,蜂蜜作为碳水化合物负荷的替代来源:一项随机盲法比较研究。","authors":"Karthik Krishnan, Siti Khatijah Abdul Razak, Mohd Zulkifli Mustafa, Najib Majdi Yaacob, Zalina Zahari, Mohd Shahrulsalam Mohd Shah, Andee Dzulkarnaen Zakaria","doi":"10.21315/mjms-06-2024-419","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Enhanced Recovery After Surgery (ERAS) is a multimodal perioperative care programme aimed at expediting recovery, reducing complications and minimising hospital stay by mitigating the metabolic stress response to surgery. One key shift in ERAS protocols is the replacement of traditional overnight fasting with carbohydrate-loading. Prolonged fasting increases insulin resistance, reduces cellular glucose uptake and glycogen formation, and may lead to hyperglycaemia. While maltodextrin is commonly used for carbohydrate-loading, it has a high glycaemic index and limited nutritional value. Kelulut Honey, a natural product rich in Trehalulose (a low-GI sugar), antioxidants, proteins, and vitamins may serve as a beneficial alternative.</p><p><strong>Methods: </strong>A randomised double-blind controlled trial involving 64 patients was conducted to evaluate the safety and efficacy of Kelulut Honey as a carbohydrate-loading agent in patients undergoing elective intra-abdominal surgery. Participants received either Kelulut Honey or commercial maltodextrin (Carborie<sup>®</sup>) according to ERAS protocol. Outcomes assessed included insulin resistance, residual gastric volume (RGV) and post-operative recovery parameters.</p><p><strong>Results: </strong>No significant difference was observed in blood glucose levels between the two groups. Average blood glucose at induction ranged from 5.3 to 5.6 mmol/L, with post-operative levels remaining below 10 mmol/L. Most participants passed flatus within 12 hours post-operatively, with over half ambulating and tolerating clear fluids within the same period. No significant differences were noted between groups in terms of complications, length of stay, pain control, or functional recovery. Intention-to-treat analysis confirmed comparable outcomes across all primary and secondary endpoints.</p><p><strong>Conclusion: </strong>Kelulut Honey is a safe and effective alternative to conventional carbohydrate drinks for pre-operative carbo-loading in abdominal surgery. It supports a modern shift away from the traditional surgical dogma of overnight fasting, with equivalent outcomes in glynaecmic control, RGV, and recovery compared to maltodextrin-based solutions.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"32 2","pages":"50-63"},"PeriodicalIF":1.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12513527/pdf/","citationCount":"0","resultStr":"{\"title\":\"Kelulut Honey as an Alternate Source of Carbo-Loading in Abdominal Surgery Involving the Digestive System: A Randomised Blinded Comparative Study.\",\"authors\":\"Karthik Krishnan, Siti Khatijah Abdul Razak, Mohd Zulkifli Mustafa, Najib Majdi Yaacob, Zalina Zahari, Mohd Shahrulsalam Mohd Shah, Andee Dzulkarnaen Zakaria\",\"doi\":\"10.21315/mjms-06-2024-419\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Enhanced Recovery After Surgery (ERAS) is a multimodal perioperative care programme aimed at expediting recovery, reducing complications and minimising hospital stay by mitigating the metabolic stress response to surgery. One key shift in ERAS protocols is the replacement of traditional overnight fasting with carbohydrate-loading. Prolonged fasting increases insulin resistance, reduces cellular glucose uptake and glycogen formation, and may lead to hyperglycaemia. While maltodextrin is commonly used for carbohydrate-loading, it has a high glycaemic index and limited nutritional value. Kelulut Honey, a natural product rich in Trehalulose (a low-GI sugar), antioxidants, proteins, and vitamins may serve as a beneficial alternative.</p><p><strong>Methods: </strong>A randomised double-blind controlled trial involving 64 patients was conducted to evaluate the safety and efficacy of Kelulut Honey as a carbohydrate-loading agent in patients undergoing elective intra-abdominal surgery. Participants received either Kelulut Honey or commercial maltodextrin (Carborie<sup>®</sup>) according to ERAS protocol. Outcomes assessed included insulin resistance, residual gastric volume (RGV) and post-operative recovery parameters.</p><p><strong>Results: </strong>No significant difference was observed in blood glucose levels between the two groups. Average blood glucose at induction ranged from 5.3 to 5.6 mmol/L, with post-operative levels remaining below 10 mmol/L. Most participants passed flatus within 12 hours post-operatively, with over half ambulating and tolerating clear fluids within the same period. No significant differences were noted between groups in terms of complications, length of stay, pain control, or functional recovery. Intention-to-treat analysis confirmed comparable outcomes across all primary and secondary endpoints.</p><p><strong>Conclusion: </strong>Kelulut Honey is a safe and effective alternative to conventional carbohydrate drinks for pre-operative carbo-loading in abdominal surgery. It supports a modern shift away from the traditional surgical dogma of overnight fasting, with equivalent outcomes in glynaecmic control, RGV, and recovery compared to maltodextrin-based solutions.</p>\",\"PeriodicalId\":47388,\"journal\":{\"name\":\"Malaysian Journal of Medical Sciences\",\"volume\":\"32 2\",\"pages\":\"50-63\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12513527/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Malaysian Journal of Medical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21315/mjms-06-2024-419\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaysian Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21315/mjms-06-2024-419","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:手术后增强恢复(ERAS)是一种多模式围手术期护理方案,旨在通过减轻手术后代谢应激反应来加速恢复,减少并发症和减少住院时间。ERAS方案的一个关键转变是用碳水化合物负荷代替传统的过夜禁食。长期禁食增加胰岛素抵抗,减少细胞葡萄糖摄取和糖原形成,并可能导致高血糖。虽然麦芽糊精通常用于碳水化合物负荷,但它的血糖指数很高,营养价值有限。Kelulut蜂蜜是一种富含海藻糖(一种低gi糖)、抗氧化剂、蛋白质和维生素的天然产品,可能是有益的替代品。方法:对64例患者进行随机双盲对照试验,评价Kelulut Honey作为糖负荷剂用于择期腹腔手术患者的安全性和有效性。参与者根据ERAS方案接受Kelulut Honey或商业麦芽糊精(Carborie®)。评估的结果包括胰岛素抵抗、胃残量(RGV)和术后恢复参数。结果:两组患者血糖水平无明显差异。诱导时的平均血糖为5.3 ~ 5.6 mmol/L,术后血糖水平低于10 mmol/L。大多数参与者在术后12小时内排便,超过一半的患者在同一时间内行走并耐受透明液体。在并发症、住院时间、疼痛控制或功能恢复方面,两组间无显著差异。意向治疗分析证实了所有主要和次要终点的可比结果。结论:克鲁鲁特蜂蜜是一种安全有效的替代常规碳水化合物饮料的腹部手术术前碳水化合物补充方法。它支持从传统的隔夜禁食手术教条的现代转变,与基于麦芽糊精的解决方案相比,在糖代谢控制、RGV和恢复方面具有相同的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Kelulut Honey as an Alternate Source of Carbo-Loading in Abdominal Surgery Involving the Digestive System: A Randomised Blinded Comparative Study.

Background: Enhanced Recovery After Surgery (ERAS) is a multimodal perioperative care programme aimed at expediting recovery, reducing complications and minimising hospital stay by mitigating the metabolic stress response to surgery. One key shift in ERAS protocols is the replacement of traditional overnight fasting with carbohydrate-loading. Prolonged fasting increases insulin resistance, reduces cellular glucose uptake and glycogen formation, and may lead to hyperglycaemia. While maltodextrin is commonly used for carbohydrate-loading, it has a high glycaemic index and limited nutritional value. Kelulut Honey, a natural product rich in Trehalulose (a low-GI sugar), antioxidants, proteins, and vitamins may serve as a beneficial alternative.

Methods: A randomised double-blind controlled trial involving 64 patients was conducted to evaluate the safety and efficacy of Kelulut Honey as a carbohydrate-loading agent in patients undergoing elective intra-abdominal surgery. Participants received either Kelulut Honey or commercial maltodextrin (Carborie®) according to ERAS protocol. Outcomes assessed included insulin resistance, residual gastric volume (RGV) and post-operative recovery parameters.

Results: No significant difference was observed in blood glucose levels between the two groups. Average blood glucose at induction ranged from 5.3 to 5.6 mmol/L, with post-operative levels remaining below 10 mmol/L. Most participants passed flatus within 12 hours post-operatively, with over half ambulating and tolerating clear fluids within the same period. No significant differences were noted between groups in terms of complications, length of stay, pain control, or functional recovery. Intention-to-treat analysis confirmed comparable outcomes across all primary and secondary endpoints.

Conclusion: Kelulut Honey is a safe and effective alternative to conventional carbohydrate drinks for pre-operative carbo-loading in abdominal surgery. It supports a modern shift away from the traditional surgical dogma of overnight fasting, with equivalent outcomes in glynaecmic control, RGV, and recovery compared to maltodextrin-based solutions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Malaysian Journal of Medical Sciences
Malaysian Journal of Medical Sciences MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
2.70
自引率
0.00%
发文量
89
审稿时长
9 weeks
期刊介绍: The Malaysian Journal of Medical Sciences (MJMS) is a peer-reviewed, open-access, fully online journal that is published at least six times a year. The journal’s scope encompasses all aspects of medical sciences including biomedical, allied health, clinical and social sciences. We accept high quality papers from basic to translational research especially from low & middle income countries, as classified by the United Nations & World Bank (https://datahelpdesk.worldbank.org/knowledgebase/ articles/906519), with the aim that published research will benefit back the bottom billion population from these countries. Manuscripts submitted from developed or high income countries to MJMS must contain data and information that will benefit the socio-health and bio-medical sciences of these low and middle income countries. The MJMS editorial board consists of internationally regarded clinicians and scientists from low and middle income countries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信